-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Alzamend Neuro, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q2 2025.
- Alzamend Neuro, Inc. Operating Income (Loss) for the quarter ending July 31, 2025 was -$2.7M, a 181% decline year-over-year.
- Alzamend Neuro, Inc. Operating Income (Loss) for the twelve months ending July 31, 2025 was -$6.23M, a 15.5% increase year-over-year.
- Alzamend Neuro, Inc. annual Operating Income (Loss) for 2024 was -$4.5M, a 54.8% increase from 2023.
- Alzamend Neuro, Inc. annual Operating Income (Loss) for 2023 was -$9.94M, a 33.2% increase from 2022.
- Alzamend Neuro, Inc. annual Operating Income (Loss) for 2022 was -$14.9M, a 20.7% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)